People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. | — | Pharmaceuticals | Series D+ | $527.4M | $2.4B | 2018 |
| SH Parent, Inc. | — | Other | Series C | $145.3M | $582.5M | 2021 |
| Talphera, Inc. | — | Pharmaceuticals | Series B | $97.4M | $74.2M | 2022 |
Marina Bozilenko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Marina Bozilenko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Wan | 1 | 10 |
| Stephen Hoffman | 1 | 7 |
| Frank McCormick | 1 | 7 |
| EDWARD BROWN | 1 | 6 |
| Guy Nohra | 1 | 5 |
| Howard Rosen | 1 | 5 |
| Ian Clark | 1 | 5 |
| James Holmes | 1 | 5 |
| Mark Edwards | 1 | 4 |
| Howard B. Rosen | 1 | 4 |
| James Welch | 1 | 4 |
| Jason Becker | 1 | 3 |
| James Whitcomb | 1 | 3 |
| Cynthia Butitta | 1 | 3 |
| Gorjan Hrustanovic | 1 | 3 |
| Richard King | 1 | 3 |
| James H. Welch | 1 | 3 |
| William Wrigley Jr. | 1 | 3 |
| Jill Broadfoot | 1 | 2 |
| Cyrus Harmon | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.